Chemoimmunotherapy with inotuzumab ozogamicin combined with mini ‐hyper‐CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome–negative acute lymphoblastic leukemia in first salvage
Cancer, EarlyView.
Source: Cancer - Category: Cancer & Oncology Authors: Elias Jabbour,
Koji Sasaki,
Farhad Ravandi,
Xuelin Huang,
Nicholas J. Short,
Maria Khouri,
Partow Kebriaei,
Jan Burger,
Joseph Khoury,
Jeffrey Jorgensen,
Nitin Jain,
Marina Konopleva,
Guillermo Garcia ‐Manero,
Tapan Kadia,
Jorge Cortes,
J Source Type: research